ADJUVANT THERAPY WITH TOLAZAMIDE AND INSULIN IMPROVES METABOLIC CONTROL IN TYPE-I DIABETES-MELLITUS

被引：18

作者：

KABADI, UM ^{[1
]}

机构：

[1] UNIV IOWA,COLL MED,IOWA CITY,IA 52242

来源：

关键词：

D O I：

10.2337/diacare.8.5.440

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：440 / 446

页数：7

共 32 条

[1]

ALLEN BT, 1983, DIABETES, V32, pA35

[2]

ALLEN BT, 1983, DIABETES S1, V32, P138

[3]

BACHMANN W, 1981, DIABETOLOGIA, V21, P245

[4]

Bar R S, 1979, Adv Intern Med, V24, P23

BECKNIELSEN, H ;

PEDERSEN, O ;

LINDSKOV, HO .

ACTA ENDOCRINOLOGICA, 1979, 90 (03) :451-462

[6] POTENTIATION OF HEPATIC ACTION OF INSULIN BY CHLORPROPAMIDE [J].

BLUMENTHAL, SA .

[7]

BOLLI GB, 1984, NEW ENGL J MED, V310, P1706, DOI 10.1056/NEJM198406283102605

[8]

BUTTERFIELD WJH, 1967, TOLBUTAMIDE 10 YEARS, P196

CAHILL, GF ;

HASTINGS, AB ;

ASHMORE, J .

[10]

COLWELL AR, 1964, METABOLISM, V13, P310